Cargando…
Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle
Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant disease and has the worst prognosis and survival rate. TUBA1C is a microtubule component implicated in multiple cancers, however, the clinical significance and biological functions of TUBA1C in the progression of PDAC remain u...
Autores principales: | Albahde, Mugahed Abdullah Hasan, Zhang, Piao, Zhang, Qiuqiang, Li, Guoqi, Wang, Weilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033491/ https://www.ncbi.nlm.nih.gov/pubmed/32117719 http://dx.doi.org/10.3389/fonc.2020.00049 |
Ejemplares similares
-
PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Ge, Ouyang, et al.
Publicado: (2021) -
The Many Faces of Wnt and Pancreatic Ductal Adenocarcinoma Oncogenesis
por: Weekes, Colin D., et al.
Publicado: (2011) -
Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2021) -
Elevated expression of TUBA1C in breast cancer predicts poor prognosis
por: Zhao, Yi, et al.
Publicado: (2023) -
The tuba family /
por: Bevan, Clifford
Publicado: (1978)